financetom
Business
financetom
/
Business
/
Karur Vysya Bank aims to increase commercial share of loan book to 33%
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Karur Vysya Bank aims to increase commercial share of loan book to 33%
Oct 17, 2023 7:40 AM

B Ramesh Babu, the Managing Director and CEO of Karur Vysya Bank aims to increase the share of the commercial space in the overall loan book to 33%.

"Our intention is to have a 33% book in the commercial space where the yields are good. Agriculture as well as retail, we want to retain around 20-22%, and the balanced portion of 20-21% will be corporate," he said in an interview with CNBC-TV18.

To support the loan targets, Karur Vysya Bank is targeting loan growth of more than 15% for the current year.

However, there are challenges on the horizon, particularly concerning NIMs. The bank is currently experiencing pressure on its NIMs due to the increased cost of deposits. Despite setting a guidance of around 4% for the second quarter, the bank is currently ahead of this target.

Babu, however, remains optimistic that at the exit quarter of this year, the NIM will be around 3.8%. He said the NIM pressure is not a cause for concern, as the bank is working to compensate for the shortfall in NIMs through other assets.

Karur Vysya Bank's Return on Assets (RoA) was at a decade-high of 1.57% for the current quarter and Babu expects this strong performance to continue, with a projected RoA of 1.6% for FY24 at the exit quarter.

Also Read | Ashutosh Mishra of Ashika Stock Broking prefers these banking stocks

The bank reported substantial year-on-year growth in its key financial metrics in the September quarter as per its latest business update. Total business stood at Rs 1,53,514 crore, marking a 14.15% growth compared to the same period in the previous year. Total deposits also surged to Rs 83,068 crore, reflecting a 13.17% growth year-on-year.

For more details, watch the accompanying video

(Edited by : Shweta Mungre)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
'Fantastic Four' actress Jessica Alba to step down as creative chief at Honest Company
'Fantastic Four' actress Jessica Alba to step down as creative chief at Honest Company
Apr 9, 2024
(Reuters) - Personal care and baby products maker Honest Company ( HNST ) said on Tuesday its founder, actress Jessica Alba, would be stepping down from her role as the chief creative officer. Alba, known for her roles in movies such as Fantastic Four, Honey and Good Luck Chuck, had founded the company in 2012 and it began trading on...
Illumina CFO Goswami to depart, former Summit Therapeutics exec Dhingra to succeed
Illumina CFO Goswami to depart, former Summit Therapeutics exec Dhingra to succeed
Apr 9, 2024
April 9 (Reuters) - Illumina ( ILMN ) said on Tuesday Chief Financial Officer Joydeep Goswami would leave the gene sequencing company and would be succeeded by former Summit Therapeutics' executive Ankur Dhingra. Goswami, who has more than two decades of experience in the life sciences industry, was the CFO since early 2023 and will serve as an adviser till...
Piper Sandler On Tilray Brands; Guidance Bar Lowered, US Regulatory Outlook Unclear
Piper Sandler On Tilray Brands; Guidance Bar Lowered, US Regulatory Outlook Unclear
Apr 9, 2024
04:59 PM EDT, 04/09/2024 (MT Newswires) -- According to Michael Lavery in a note published late Tuesday afternoon, Piper Sandler believes Tilray Brands ( TLRY ) stands out from competitors with direct access to the EU, but it also expects cannabis stocks (TLRY included) will continue to trade largely on US regulatory expectations. Lavery noted the US regulatory outlook is...
Illumina Names Ankur Dhingra as Chief Financial Officer
Illumina Names Ankur Dhingra as Chief Financial Officer
Apr 9, 2024
05:01 PM EDT, 04/09/2024 (MT Newswires) -- Illumina ( ILMN ) said late Tuesday that it appointed Ankur Dhingra as its chief financial officer. Dhingra, formerly CFO at Summit Therapeutics (SMMT), replaces Joydeep Goswami, who decided to leave the company but will stay on in an advisory role through June 30. Additionally, Illumina ( ILMN ) appointed Jakob Wedel as...
Copyright 2023-2026 - www.financetom.com All Rights Reserved